Online citations, reference lists, and bibliographies.

Psoriasis And Dry Skin: The Impact Of Moisturizers

J. Fluhr, E. Berardesca, R. Darlenski
Published 2012 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
In the dawn of twenty-first century, psoriasis is considered a chronic, systemic, inflammatory disease that affects skin and its appendages. Dermatology has entered the era of specific systemic treatments with biological therapeutic agents. On the other hand, emollients and moisturizers are still essential in the topical adjuvant treatment of psoriasis not only in the remission phase. They are excellent supplements to the classical and novel treatments and help to reduce the scale load of the individual patient. Their major role is to support the normalizing of hyperproliferation, differentiation and apoptosis. In addition, they exert anti-inflammatory effects, e.g. through physiological lipids. The improvement of epidermal barrier function and stratum corneum hydration makes the skin resistant to external stressors, causing the Kobner phenomenon in psoriasis.
This paper references
10.1007/BF02505052
Urea-containing moisturizers influence barrier properties of normal skin
M. Lodén (2006)
10.1001/archderm.1975.01630180068008
Percutaneous absorption of salicylic acid.
J. R. Taylor (1975)
10.1111/j.1365-2230.1986.tb00457.x
Salicyclic acid gel for scalp psoriasis
S. Going (1986)
Effects of topical petrolatum and salicylic acid upon skin photoreaction to UVA.
B. Birgin (2005)
The influence of urea on the penetration kinetics of topically applied corticosteroids.
W. Wohlrab (1984)
On the influence of bath oils with different solvent characteristics and different amounts of a non-ionic tenside on the hydration and barrier function of the stratum corneum
J. Fluhr (1998)
10.1016/J.IJPHARM.2004.11.032
Cutaneous bioassay of salicylic acid as a keratolytic.
S. Bashir (2005)
10.1016/j.jaad.2008.12.032
Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies.
A. Menter (2009)
10.1007/978-3-642-83754-8_1
Review Harnstoff in der Dermatologie II
K. Müller (1989)
Hydratisierender und die Steroid-penetration modifizierender Effekt von Harnstoff und Glycerin in Abhängigkeit von der verwendeten Grundlage
J. Fluhr (1998)
10.1111/J.1600-0781.2005.00157.X
Evaluation of vaseline oil applied prior to UVB TL01 phototherapy in the treatment of psoriasis.
K. Penven (2005)
Influence of emulsions with and without urea on water-binding capacity of the stratum corneum
J. Bettinger (1995)
10.1007/s001050050281
Stellenwert der adjuvanten Basistherapie bei chronisch-rezidivierenden Hauterkrankungen Neurodermitis atopica/Psoriasis vulgaris
E. Schöpf (1995)
[Salicylate poisoning by percutaneous resorption].
E. Diem (1973)
Adjuvant role of a new emollient cream in patients with palmar and/or plantar psoriasis: a pilot randomized open-label study.
N. Cassano (2010)
10.1159/000232310
Future perspectives in the treatment of psoriasis.
K. Wippel-Slupetzky (2009)
10.1111/j.1468-3083.2011.04059.x
In touch with psoriasis: topical treatments and current guidelines.
G. Murphy (2011)
10.1046/J.1365-4362.1999.00500.X
The role of salicylic acid in the treatment of psoriasis.
M. Lebwohl (1999)
Moisturizers: what they are and how they work.
L. Cw (2001)
[Effect of urea on the water binding capacity of the human stratum corneum].
W. Wohlrab (1988)
10.1111/J.1365-2710.2007.00803.X
Evaluation of skin penetration of topically applied drugs in humans by cutaneous microdialysis: acyclovir vs. salicylic acid.
A. Klimowicz (2007)
[Skin resorption of salicylic acid in psoriasis patients and persons with healthy skin].
W. Arnold (1979)
10.3109/09546639709160944
Emollients as adjuvant therapy for psoriasis
A. Finlay (1997)
10.1111/j.1365-2133.1980.tb06590.x
Detection of the action of salicylic acid on the normal stratum corneum
D. L. Roberts (1980)
10.1111/J.1600-0846.2004.00058.X
Use of an intraluminal guide wire in linear microdialysis probes: effect on recovery?
A. Klimowicz (2004)
[Promoting penetration of locally applied substances by urea].
G. Stüttgen (1989)
10.1016/j.jaad.2008.02.040
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics.
A. Gottlieb (2008)
Effects of topical petrolatum and salicylic acid on the erythemogenicity of UVB.
E. Fetil (2002)
Optimizing topical therapies for treating psoriasis: a consensus conference.
Joshua A. Zeichner (2010)
10.1007/BF00373431
Stratum corneum dynamic function measurements after moisturizer or irritant application
P. Treffel (1995)
Klinische Wirkung von Salicylsäure und hochdosiertem Harnstoff bei Applikation in standardisierten Magistralrezepturen aus dem Neuen Rezeptur Formularium (NRF)
M. Gloor (2001)
[Clinical effect of salicylic acid and high dose urea applied according to the standardized New German Formulary].
M. Gloor (2001)
[Recovery rate of externally administered glucocorticoids on the skin surface].
W. Wohlrab (1986)
10.1093/oxfordjournals.qjmed.a068363
Adult salicylate poisoning: deaths and outcome in patients with high plasma salicylate concentrations.
B. J. Chapman (1989)
[Investigations on the mechanism of the activity of urea upon the epidermis (author's transl)].
W. Wohlrab (1976)
10.1007/BF00741846
“Keratolytic” effect of salicylic acid
C. Huber (1977)
10.1111/j.1365-2133.1987.tb04123.x
In vivo measurement of the keratolytic effect of salicylic acid in three ointment formulations
T. Nook (1987)
10.1111/j.1365-2133.1993.tb03338.x
Highly purified omega‐3‐polyunsaturated fatty acids for topical treatment of psoriasis. Results of a double‐blind, placebo‐controlled multicentre study
H.‐H. HENNEICKE‐VON ZEPELIN (1993)
[Salicylic acid and urea--possible modification of the keratolytic effect of salicylic acid by urea].
B. Gabard (1989)
The effects of a topical application of urea cream on the function of pathological stratum corneum
Y. Sasaki (1989)
10.1046/j.1365-3156.1996.d01-91.x
Management of psoriasis with Aloe vera extract in a hydrophilic cream: a placebo-controlled, double-blind study.
T. Syed (1996)
10.1080/00015550510027757
Novel quantitative immunofluorescent technique reveals improvements in epidermal cell populations after mild treatment of psoriasis.
M. van Duijnhoven (2005)
10.1159/000252139
The interaction of anthralin, salicylic acid and zinc oxide in pastes.
H. Hulsebosch (1972)
10.1007/BF00581674
Untersuchungen zum mechanismus der harnstoffwirkung auf die haut
W. Wohlrab (2004)
10.1111/j.1365-2230.1992.tb00194.x
Topical fish oil in psoriasis—a controlled and blind study
S. Escobar (1992)
The use of emollients as sophisticated therapy in dermatology.
Ivana Nola (2003)
[Parvovirus B19 infection: not confined to exanthema of erythema infectiosum].
Schwarz Tf (1989)
10.1111/j.1365-2133.1989.tb01335.x
Topical eicosapentaenoic acid (EPA) in the treatment of psoriasis
Catherine E.Dewsbury (1989)
10.1046/j.1467-2494.2000.00001.x
Dry skin, moisturization and corneodesmolysis
Harding (2000)
10.1056/NEJM199503023320907
Treatment of psoriasis.
M. Greaves (1995)
10.1016/B978-0-12-024924-4.50012-2
Lipids in normal and pathological desquamation.
M. Williams (1991)
10.1159/000250902
Effect of topical salicylic acid on animal epidermopoiesis.
E. Weirich (1978)
10.1111/j.1600-0536.1997.tb00213.x
Barrier recovery and influence of irritant stimuli in skin treated with a moisturizing cream
M. Lodén (1997)
Moisturizing cream ameliorates dryness and desquamation in participants not receiving topical psoriasis treatment.
Z. Draelos (2008)
10.1111/j.1468-3083.2010.03600.x
Psoriasis: an epidemiological evaluation of disease burden in 590 patients.
N. Meyer (2010)
[Chronic percutaneous salicylic acid poisoning].
C. Luderschmidt (1975)
10.1001/archderm.1964.01600060080013
PERCUTANEOUS SALICYLIC ACID INTOXICATION IN PSORIASIS.
J. F. Vonweiss (1964)
10.1111/j.1600-0625.2009.00903.x
Emollient for maintenance therapy after topical corticotherapy in mild psoriasis
S. Seité (2009)
[Keratoplastic effect of salicyclic acid, sulfur and a tensio-active mixture].
M. Gloor (1984)
Salicylate intoxication after use of topical salicylic acid ointment by a patient with psoriasis.
J. Péč (1992)
10.1046/J.1468-3083.2000.00006.X
Double-blind clinical study reveals synergistic action between alpha-hydroxy acid and betamethasone lotions towards topical treatment of scalp psoriasis.
K. Kostarelos (2000)
10.3109/15563659609013814
Salicylism from topical salicylates: review of the literature.
J. Brubacher (1996)
10.1159/000069029
The Topical Treatment of Psoriasis
P. V. D. van de Kerkhof (2003)
10.1111/j.1365-2133.1986.tb02111.x
Short and long‐term risks of topical drugs
A. Zesch (1986)
10.1007/978-3-642-83754-8_13
Salizylsäure und Harnstoff — mögliche Beeinflussung der keratolytischen Wirkung von Salizylsäure durch Harnstoff
B. Gabard (1989)
10.1007/BF00562229
Die wirkung der salicylsäure auf die proliferationskinetik psoriatischer epidermiszellen
H. Pullmann (1975)
The use of therapeutic moisturizers in various dermatologic disorders.
J. Bikowski (2001)
10.1080/000155599750011705
Effect of long-term use of moisturizer on skin hydration, barrier function and susceptibility to irritants.
E. Held (1999)
10.1001/archderm.1974.01630010038008
Percutaneous penetration of hydrocortisone with urea.
R. Feldmann (1974)
10.1007/978-3-642-83754-8
Harnstoff in der Dermatologie
W. Raab (1989)
10.1046/J.1365-4362.2000.00986-3.X
Treatment of scalp seborrheic dermatitis and psoriasis with an ointment of 40% urea and 1% bifonazole.
A. Shemer (2000)
10.1159/000018063
Percutaneous Absorption of Salicylic Acid in Man after Topical Administration of Three Different Formulations
F. Schwarb (1999)
[Urea in dermatology I].
K. Müller (1989)
10.2147/DDDT.S10494
Comparative assessment of biologics in treatment of psoriasis: drug design and clinical effectiveness of ustekinumab
I. García-Valladares (2011)
10.1111/j.1365-2133.1976.tb04370.x
The inhibiting effect of soft paraffin on the Köbner response in psoriasis
J. Comaish (1976)
[Modulation of drug penetration in the skin].
J. Kalbitz (1996)
O/W emulsions compromise the stratum corneum barrier and improve drug penetration.
M. Gloor (2003)
[The influence of ceratolytics and moisturizers on the bio-availability of triamcinolone acetonide following topical application (author's transl)].
M. Gloor (1980)
Topical treatment by urea reduces epidermal hyperproliferation and induces differentiation in psoriasis.
I. Hagemann (1996)
10.4065/76.9.943
Topical therapies for localized psoriasis.
P. Witman (2001)
ORAL AND TOPICAL SUPPLEMENTATION OF LINOLEIC ACID AND SKIN DISEASE
E. Berardesca (1998)
Modulation der Wirkstoffpenetration in die Haut
J. Kalbitz (1996)
[Anthralin-salicylic acid therapy of psoriasis. Cignolin-salicylic acid-vaseline treatment and Lasan paste in a right-left comparison].
U. Runne (1974)
[The effect of salicylic acid on epidermal cell proliferation kinetics in psoriasis. Autoradiographic in vitro-investigations(author's transl)].
H. Pullmann (1975)
10.1046/J.1365-2230.1998.00361.X
Effects of glycolic acid on psoriasis.
B. Erardesca (1998)
10.1007/978-3-642-83754-8_4
Penetrationsförderung lokal applizierter Wirkstoffe durch Harnstoff
G. Stüttgen (1989)
10.1111/j.1365-2133.1976.tb00825.x
Studies on the effect of salicylic acid on normal skin
M. Davies (1976)
10.1007/BF02000996
Untersuchungen über die Pharmakologie und Pharmakodynamik von Salben und salbeninkorporierten Medikamenten
C. Moncorps (2005)
10.1007/bf00562229
Die wirkung der salicylsure auf die proliferationskinetik psoriatischer epidermiszellen: Autoradiographischein vitro-Untersuchungen
H. Pullmann (1975)
Water-in-oil emollients as steroid-sparing adjunctive therapy in the treatment of psoriasis.
K. Watsky (1992)
10.1007/s001050050479
Lebensbedrohliche Salicylatintoxikation durch perkutane Resorption bei einer schweren Ichthyosis vulgaris
R. Germann (1996)
10.1111/j.1365-2133.2007.08135.x
Psoriasis: evolution of pathogenic concepts and new therapies through phases of translational research
E. Guttman-Yassky (2007)
10.1159/000093984
‘Keratolytic’ Properties of Benzoyl Peroxide and Retinoic Acid Resemble Salicylic Acid in Man
J. Waller (2006)
10.1111/J.1468-3083.2004.01186.X
A double-blind, placebo-controlled study of a commercial Aloe vera gel in the treatment of slight to moderate psoriasis vulgaris.
E. Paulsen (2005)
10.1111/j.1365-2230.2005.01773.x
Electrical measurement of moisturizing effect on skin hydration and barrier function in psoriasis patients
J. Rim (2005)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar